Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells

Clinical Cancer Research

Volumn 10, Issue 17, 2004, Pages 5895-5901

  Gessi, Stefania ^a   Cattabriga, Elena ^a   Avitabile, Arianna ^a   Gafa, Roberta ^a   Lanza, Giovanni ^a   Cavazzini, Luigi ^a   Bianchi, Nicoletta ^a   Gambari, Roberto ^a   Feo, Carlo ^a   Liboni, Alberto ^a   Gullini, Sergio ^a   Leung, Edward ^b   Mac Lennan, Stephen ^b   Borea, Pier Andrea ^a,c  

^a UNIVERSITY OF FERRARA   (Italy)

^b King Pharmaceuticals   (United States)

^c Pharmacology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A3 RECEPTOR; NUCLEOSIDE; RECEPTOR SUBTYPE; TUMOR MARKER; MESSENGER RNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CANCER PATIENT; CELL PROLIFERATION; COLON CARCINOGENESIS; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLID TUMOR; TUMOR CELL; CANCER STAGING; COLLOID CARCINOMA; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; MUCOSA; PATHOLOGY; PROGNOSIS;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; BLOOD CELLS; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MUCOUS MEMBRANE; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ADENOSINE A3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 4444247043     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1134-03     Document Type: Article

References (33)

1. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-52.
2. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001;41:775-87.
3. Poulsen SA, Quinn RJ. Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem 1998;6:619-41.
4. Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinoma contains immunosuppressive concentrations of adenosine. Cancer Res 1997;57:2602-5.
5. 3 receptor. Cancer Res 1994;54:3521-6.
6. Ohta A, Sitkovsky M. Role of G-protein-coupled receptors in down-regulation of inflammation and protection from tissue damage. Nature (Lond) 2001;414:916-20.
7. 2B receptors in angiogenic factor regulation. Circ Res 2002;90:531-8.
8. 3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells. Biochem Biophys Res Commun 1997;241:297-304.
9. 3 adenosine receptor affects cell cycle progression and cell growth. Naunyn-Schmiedeberg's Arch Pharmacol 2000;361:225-34.
10. Fishman P, Bar-Yehuda S, Vagman L. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res 1998;58:3181-7.
11. 3 adenosine receptor. J Cell Physiol 2001;186:19-23.
12. Merighi S, Mirandola P, Milani D, et al. Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Investig Dermatol 2002;119:923-33.
13. 2B purinoceptor. Circ Res 2000;86:76-85.
14. 3 adenosine receptor as a target for cancer therapy. Anticancer Drugs 2002;13:1-8.
15. 3 adenosine receptor agonist CF101. Br J Cancer 2003;89:1552-8.
16. 3 adenosine receptors in Jurkat T cells. Br J Pharmacol 2001;134:116-26.
17. Merighi S, Varani K, Gessi S, et al. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375. Br J Pharmacol 2001;134:1215-26.
18. Suh BC, Kim TD, Lee JU, Seong JK, Kim KT. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Br J Pharmacol 2001;134:132-42.
19. 3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol 2002;61:415-24.
20. 3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res 2002;269:230-6.
21. Hellmich MR, Rui X-L, Hellmich HL, et al. Human colorectal cancers express a constitutively active cholecystochinin-B/gastrin receptor that stimulates cell growth. J Biol Chem 2000;275:32122-8.
22. Brodde OE, Beckering JJ, Michel MC. Human heart β-adrenoceptors: a fair comparison with lymphocyte β-adrenoceptors? Trends Pharmacol Sci 1987;8:403-7.
23. 2- adrenoceptor alterations in patients with essential hypertension. Br J Clin Pharmacol 1999;47:167-72.
24. 2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J 2002;17:280-2.
25. 3 adenosine receptors. Mol Pharmacol 2000;57:968-75.
26. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 1976;72:248-54.
27. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 1993;11:1026-30.
28. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 1980;107:220-39.
29. Merighi S, Mirandola P, Varani K, et al. A glance at adenosine receptors: novel target for antitumor therapy. Pharmacol Ther 2004;100:31-48.
30. Fishman P, Madi L, Bar-Yehuda S, et al. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene 2002;21:4060-4.
31. 3 adenosine receptor agonists. Neoplasia 2001;3:125-31.
32. Barry CP, Lind SE. Adenosine-mediated killing of cultured epithelial cancer cells. Cancer Res 2000;60:1887-94.
33. 3 receptors in the human enteric nervous system. J Comp Neurol 2001;439:46-64.